Literature DB >> 6436876

Behavioral responses to apomorphine and amphetamine in differentially housed mice.

C A Wilmot, C Vander Wende, M T Spoerlein.   

Abstract

The climbing response to apomorphine (AP, 0.075-3.0 mg/kg) and the motor activity response to amphetamine (AMP, 0,3-5.0 mg/kg) were determined in grouped or socially isolated mice. After 4 weeks of differential housing commencing at 5 weeks of age, the individually housed mice showed an increased response only to low doses of these drugs. The responses of the group-housed mice at 5 or 9 weeks of age were identical, ruling out an aging component to the differential responsiveness. Also, the response of separate groups of naive mice to acute treatments of saline, AP (0.15 and 3.0 mg/kg), and AMP (0.3 and 5.0 mg/kg) was examined at 1, 2, 3, and 4 weeks of differential housing. With respect to age-matched group-housed mice, a significantly greater climbing response to AP (0.15 mg/kg) and a significantly greater locomotor activity response to AMP (0.3 mg/kg) were seen after 1 and 3 weeks of individual housing. There were no significant differences in the behavioral responses to the higher doses of AP and AMP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6436876     DOI: 10.1007/bf00432036

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  21 in total

Review 1.  Aggression and central neurotransmitters.

Authors:  S N Pradhan
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

2.  Catecholamine correlates of isolation-induced aggression in mice.

Authors:  G K Hodge; L L Butcher
Journal:  Eur J Pharmacol       Date:  1975-03       Impact factor: 4.432

3.  Long-term changes in the sensitivity of pre-and postsynaptic dopamine receptors in mouse striatum evidenced by behavioural and biochemical studies.

Authors:  M P Martres; J Costentin; M Baudry; H Marcais; P Protais; J C Schwartz
Journal:  Brain Res       Date:  1977-11-11       Impact factor: 3.252

4.  Effects of social stress on the turnover of brain catecholamines and 5-hydroxytryptamine in mice.

Authors:  K Modigh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1974-02

5.  A difference in glutamate-decarboxylase activity between isolated and grouped mice.

Authors:  J M Blindermann; F V DeFeudis; M Maitre; R Misslin; P Wolff; P Mandel
Journal:  J Neurochem       Date:  1979-04       Impact factor: 5.372

6.  Evidence for dopamine receptor stimulation by apomorphine.

Authors:  N E Andén; A Rubenson; K Fuxe; T Hökfelt
Journal:  J Pharm Pharmacol       Date:  1967-09       Impact factor: 3.765

7.  Effect of dopamine receptor agonists and antagonists on release of dopamine in the rabbit caudate nucleus in vitro.

Authors:  K Starke; W Reimann; A Zumstein; G Hertting
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-10       Impact factor: 3.000

8.  Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.

Authors:  B Costall; S K Lim; R J Naylor
Journal:  Eur J Pharmacol       Date:  1981-07-17       Impact factor: 4.432

9.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

10.  Isolation induced aggression and catecholamine variations in discrete brain areas of the mouse.

Authors:  Y Tizabi; V J Massari; D M Jacobowitz
Journal:  Brain Res Bull       Date:  1980 Jan-Feb       Impact factor: 4.077

View more
  2 in total

1.  Behavioral and biochemical studies of dopamine receptor sensitivity in differentially housed mice.

Authors:  C A Wilmot; C VanderWende; M T Spoerlein
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  The postweaning social isolation in C57BL/6 mice: preferential vulnerability in the male sex.

Authors:  Susanna Pietropaolo; Philipp Singer; Joram Feldon; Benjamin K Yee
Journal:  Psychopharmacology (Berl)       Date:  2008-03-04       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.